Abstract
Tumors are heterogeneous in nature and consist of multiple cell types. Among them, cancer stem-like cells (CSCs) are suggested to be the principal cause of tumor metastasis, resistance and recurrence. Therefore, understanding the behavior of CSCs in direct and indirect irradiations is crucial for clinical radiotherapy. Here, the CSCs and their counterpart non stem-like cancer cells (NSCCs) in human HT1080 fibrosarcoma cell line were sorted and labeled, then the two cell subtypes were mixed together and chosen separately to be irradiated via a proton microbeam. The radiation-induced bystander effect (RIBE) between the CSCs and NSCCs was measured by imaging 53BP1 foci, a widely used indicator for DNA double strand break (DSB). CSCs were found to be less active than NSCCs in both the generation and the response of bystander signals. Moreover, the nitric oxide (NO) scavenger c-PTIO can effectively alleviate the bystander effect in bystander NSCCs but not in bystander CSCs, indicating a difference of the two cell subtypes in NO signal response. To our knowledge, this is the first report shedding light on the RIBE between CSCs and NSCCs, which might contribute to a further understanding of the out-of-field effect in cancer radiotherapy.
References
Mar 10, 2005·International Journal of Cancer. Journal International Du Cancer·Chunlin ShaoKevin M Prise
May 8, 2007·Cancer Research·Olga A SedelnikovaWilliam M Bonner
Sep 21, 2007·Cell Cycle·Mykyta V SokolovOlga A Sedelnikova
Nov 6, 2007·Mutation Research·Chunlin ShaoMelvyn Folkard
Mar 29, 2008·Cell Stem Cell·Christophe GinestierGabriela Dontu
May 31, 2008·Nature Reviews. Cancer·Michael BaumannRichard Hill
Sep 2, 2008·Cancer Research·Susanne Burdak-RothkammKevin M Prise
Apr 21, 2009·Nature Reviews. Cancer·Kevin M Prise, Joe M O'Sullivan
Jun 6, 2009·Cell Stem Cell·Steven M PollardPeter Dirks
Jul 3, 2010·Oncology Reports·Kanya HonokiToshifumi Tsujiuchi
Dec 15, 2010·Current Molecular Pharmacology·Tom K HeiVladimir N Ivanov
Dec 15, 2010·PloS One·Mykyta V Sokolov, Ronald D Neumann
Jan 12, 2011·Proceedings of the National Academy of Sciences of the United States of America·Dimitrios IliopoulosKevin Struhl
Mar 9, 2011·PloS One·Jennifer FitzGeraldNoel F Lowndes
Mar 23, 2011·Cell Stem Cell·Anna Merlos-SuárezEduard Batlle
Apr 30, 2011·Proceedings of the National Academy of Sciences of the United States of America·Aroumougame AsaithambyDavid J Chen
Jun 8, 2011·Nature Reviews. Clinical Oncology·Scott C Morgan, Chris C Parker
Dec 16, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Jaime Gómez-MillánJosé Mariano Ruiz de Almodóvar
Mar 24, 2012·Cancer Cell·Jeffrey A MageeSean J Morrison
Jan 5, 2013·Journal of Radiation Research·Teruaki KonishiYoshiyuki Shirakawa
May 30, 2013·Cancer Science·Rae-Kwon KimSu-Jae Lee
Jun 1, 2013·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Radosław JanuchowskiMaciej Zabel
Jul 16, 2013·Clinical Oncology : a Journal of the Royal College of Radiologists·M E LomaxP O'Neill
Jul 19, 2013·Physics in Medicine and Biology·Antje-Christin Knopf, Antony Lomax
Nov 12, 2013·Cell·Filippo G Giancotti
Nov 26, 2013·Genome Medicine·Elza C de BruinCharles Swanton
Nov 30, 2013·Nature Reviews. Drug Discovery·Chiara GorriniTak W Mak
Jan 21, 2014·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Amar DesaiStanton L Gerson
Mar 13, 2014·Cell Stem Cell·Thordur OskarssonJoan Massagué
Citations
Feb 27, 2016·Journal of Cellular Biochemistry·Seog-Young KimYong J Lee
Oct 31, 2018·International Journal of Radiation Biology·Qibin FuTuchen Huang
Apr 30, 2019·Journal of Radiation Research·Ryo SagaYoichiro Hosokawa
Oct 26, 2016·Molecular Medicine Reports·Igor S BryukhovetskiyYuri S Khotimchenko
Apr 17, 2021·Scientific Reports·Ryo SagaYoichiro Hosokawa